
Loading, please wait...

Loading, please wait...

Recent innovations in neurotechnology have led to the development of the M-CASS system, which significantly enhances deep brain stimulation efficiency. This single-stage, single-coil wireless system generates four separate adiabatic supplies. Consequently, it can independently regulate constant stimulus currents without relying on traditional, power-hungry sources. Moreover, the system maintains this regulation regardless of stimulus current levels or variations in load impedance.
The 0.25-μm CMOS M-CASS demonstrates remarkable performance in recent trials. Furthermore, it achieves a peak AC-to-stimulation efficiency of 82.2% when steering multiple 2-mA currents. This high efficiency remains stable, hovering around 80%, even when stimulus channels face different impedances. Therefore, it provides a compact and energy-efficient solution for multiple-source current-steering (MSCS) applications. This is particularly relevant for modern deep brain stimulation (DBS) devices that require high precision and long-term reliability.
Precise current steering allows clinicians to target specific neural circuits while minimizing unwanted side effects. By using a channel-optimized size control technique, the M-CASS system ensures energy-efficient delivery across all leads. Additionally, the adaptive offset control scheme optimizes power transfer across the wireless link. As a result, patients may benefit from devices that are smaller and require less frequent charging or replacement. These engineering advancements directly support the ongoing evolution of neurological care in clinical practice.
M-CASS utilizes an adiabatic supply stimulation method that avoids the use of power-hungry current sources. This approach dramatically reduces energy waste during power conversion, leading to higher overall stimulation efficiency compared to traditional designs.
Multi-channel current steering allows for more granular control of the electrical field within the brain. This precision helps in tailoring the therapy to the unique anatomy of the patient, which can potentially improve clinical outcomes in movement disorders.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of a physician or other qualified health provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Lee HS et al. A Single-Stage Single-Coil Wireless Multi-Channel Adiabatic Supply Stimulation System for Multiple Source Current Steering Deep Brain Stimulation. IEEE Trans Biomed Circuits Syst. 2026 Apr 22. doi: 10.1109/TBCAS.2026.3685780. PMID: 42019064.
Lozano AM et al. Deep brain stimulation: current challenges and future directions. Nat Rev Neurol. 2019;15(3):148-160.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed M-CASS, a wireless stimulation system for DBS that achieves 82.2% efficiency and independent multi-channel current regulation....
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today